Drug Approval | December 03, 2025
LENZ Therapeutics, Lotus Pharmaceutical submit NDA for presbyopia treatment in Korea
Presbyopia, the age-related loss of near vision, could soon be treated successfully
Presbyopia, the age-related loss of near vision, could soon be treated successfully
Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision with high best-in-category contrast & low-light performance
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
It is the first presbyopia-correcting lens implant for cataract surgery
Subscribe To Our Newsletter & Stay Updated
